(VHT) Vanguard Health Care - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US92204A5048
VHT: Pharmaceuticals, Biotechnology, Medical Devices, Healthcare Services
The Vanguard Health Care Index Fund ETF Shares (VHT) is designed to mirror the performance of a specific index comprising stocks of U.S. companies across various market capitalizations within the healthcare sector, as categorized by the Global Industry Classification Standard (GICS). By adopting a replication strategy, the fund aims to allocate its assets in a manner that closely aligns with the composition of the target index, thereby striving to maintain a proportional representation of each constituent stock.
As a healthcare-focused ETF, VHT offers investors exposure to a broad spectrum of companies operating within this sector, including pharmaceuticals, biotechnology, healthcare equipment, and healthcare services. The funds diversification across various sub-sectors and market capitalizations can help mitigate the risks associated with individual stocks, providing a more comprehensive investment approach.
Analyzing the funds recent performance and technical indicators, we observe that the current price is $245.35, slightly above its 20-day Simple Moving Average (SMA) of $243.23, indicating a short-term bullish trend. However, the 50-day SMA ($248.28) and 200-day SMA ($264.29) suggest a longer-term bearish trend. The Average True Range (ATR) of 4.05, equivalent to 1.65%, implies moderate volatility.
Given the current technical and fundamental data, a forecast for VHT can be constructed. With the 52-week high and low being $284.89 and $236.71, respectively, and considering the current price, we can anticipate a potential rebound or consolidation phase. If the healthcare sector experiences a resurgence, driven by factors such as new drug approvals, healthcare policy changes, or advancements in medical technology, VHT could potentially revisit its 52-week high. Conversely, if the sector faces challenges, the funds price may remain under pressure. With an Assets Under Management (AUM) of $15.07 billion, VHTs liquidity and scale are likely to continue attracting investors seeking broad healthcare exposure.
Based on the technical indicators and fundamental data, a potential trading strategy could involve monitoring the funds price action around its SMAs and adjusting positions accordingly. A break above the 50-day SMA could signal a short-term buying opportunity, while a decline below the 20-day SMA might indicate a selling opportunity. However, it is crucial to continuously evaluate the funds performance in the context of the overall healthcare sector and broader market trends.
Additional Sources for VHT ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
VHT ETF Overview
Market Cap in USD | 15,071m |
Category | Health |
TER | 0.10% |
IPO / Inception | 2004-01-26 |
VHT ETF Ratings
Growth Rating | 30.7 |
Fundamental | - |
Dividend Rating | 56.4 |
Rel. Strength | -13.5 |
Analysts | - |
Fair Price Momentum | 226.47 USD |
Fair Price DCF | - |
VHT Dividends
Dividend Yield 12m | 1.55% |
Yield on Cost 5y | 2.28% |
Annual Growth 5y | 7.36% |
Payout Consistency | 96.0% |
Payout Ratio | % |
VHT Growth Ratios
Growth Correlation 3m | -58.1% |
Growth Correlation 12m | -63.8% |
Growth Correlation 5y | 77.9% |
CAGR 5y | 7.39% |
CAGR/Max DD 5y | 0.42 |
Sharpe Ratio 12m | -0.17 |
Alpha | -12.86 |
Beta | 0.553 |
Volatility | 18.38% |
Current Volume | 533.6k |
Average Volume 20d | 273.4k |
As of June 16, 2025, the stock is trading at USD 250.27 with a total of 533,592 shares traded.
Over the past week, the price has changed by +1.18%, over one month by +4.38%, over three months by -6.07% and over the past year by -4.37%.
Neither. Based on ValueRay´s Analyses, Vanguard Health Care is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 30.67 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VHT is around 226.47 USD . This means that VHT is currently overvalued and has a potential downside of -9.51%.
Vanguard Health Care has no consensus analysts rating.
According to our own proprietary Forecast Model, VHT Vanguard Health Care will be worth about 251.6 in June 2026. The stock is currently trading at 250.27. This means that the stock has a potential upside of +0.55%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 251.6 | 0.5% |